<DOC>
	<DOCNO>NCT02908958</DOCNO>
	<brief_summary>To evaluate safety efficacy PEG Somatropin Injection ( Jintrolong® ) treatment short stature due endogenous growth hormone deficiency ( GHD ) broad population child .</brief_summary>
	<brief_title>Clinical Study Pegylated Somatropin Treat Children Growth Hormone Deficiency</brief_title>
	<detailed_description />
	<mesh_term>Endocrine System Diseases</mesh_term>
	<mesh_term>Dwarfism , Pituitary</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Before start treatment , child diagnose GHD accord medical history , clinical symptom sign , GH provocation test image examinators examinators . According height statistical data Chinese child 's physical development nine city 2015 , height child lower third percentile normal child 's growth curve age gender . Height velocity ( HV ) ≤5.0 cm/yr . GH provocation test two different mechanism show GH peak concentration child ＜ 10.0ng/ml . Bone age ( BA ) ≤9 year girls ≤ 10 year boys , BA 1 year less CA . Prepuberty status ( Tanner I stage ) , age ≥3 year old , girls boy acceptable . The child receive treatment growth hormone within 6 month . Subjects willing able cooperate complete schedule visit , treatment plan laboratory test procedure , sign inform consent . The child dysfunction liver kidney ( ALT ) 2 time upper limit normal value , Cr＞ upper limit normal value ) . The child positive hepatitis B core antibody ( HBc ) , hepatitis B surface antigen ( HBsAg ) hepatitis B e antigen ( HBeAg ) . The child know hypersensitivity PEG Somatropin . The child severe cardiopulmonary , hematological disease , malignant tumor , general infection immunodeficiency disease . The child potential tumor ( family history ) . The child diabetic . The child abnormal growth development , Turner 's syndrome , constitutional delay growth puberty , Laron syndrome , growth hormone receptor deficiency , short stature girl potential chromosomal abnormality . The child take part clinical trial within 3 month . Other condition exclude investigator preclude enrollment study .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>